My weight loss medicine is finally ready. I have a little anxiety about it, but they did prescribe the smallest dose.

I have long said that my main worry about GLP-1s has been the unknowns about long-term side effects, but the positives seem to outweigh the negatives. Doc wants to get some weight off of these eroding joints. They also told me exactly how to navigate the side effects.

If you also choose to go on a GLP-1, I recommend researching how the drug works, what the side effects are, and how to manage them, and how long you are willing to stay on the drug (since a lot of people regain the weight once they stop).

This drug was designed to help diabetics, and can be a godsend for stabilizing one's A1C. If you're pre-diabetic, apparently this could really help you. My A1C was fine, but they will still monitor it.

So, here goes.
Why does this feel like bungy jumping off a bridge? I guess it's the idea of something so new to me.

#GLP1 #Wegovy

FDA Approves Foundayo: The New Once-Daily GLP-1 Pill vs. Wegovy

The landscape of weight management shifted significantly on April 1, 2026, when the FDA granted approval to Foundayo (orforglipron). Produced by Eli Lilly, Foundayo is a once-daily oral GLP-1 receptor agonist designed for adults struggling with obesity or overweight conditions.   As the second oral GLP-1 pill to hit the market—following the December 2025 approval

The Common Sense Diet

Foundayo vs. Wegovy Pill: 2026 Comparison of Weight Loss Pills, Cost, and Results

https://www.dietofcommonsense.com/foundayo-vs-wegovy-pill-weight-loss/

#foundayo #wegovy #weightloss #weightlosspill #health

Foundayo vs. Wegovy Pill: 2026 Comparison of Weight Loss Pills, Cost, and Results

The 2026 landscape of obesity treatment has reached a tipping point. With the recent FDA approval of Foundayo (orforglipron) on April 1, 2026, and the late 2025 launch of the Wegovy pill, the "needle-free" era is officially here.   For millions of Americans, the shift from weekly injections to a daily pill isn't just about

The Common Sense Diet
Il est possible que mes douleurs de dos soient des effets du #Wegovy (perte de masse musculaire), et d’un manque d’hydratation.
Allons bon, explorons cette piste.
Troisième semaine à 1mg, j’ai vraiment l’impression de ressentir des effets à chaque fois à partir de J+1 après l’injection. Mais je pense que ça ne couvre pas encore la semaine.
Il me reste une injection à cette dos avant de passer à 1,7. J’ai espoir de vraiment voir la différence à partir de cette dose…
#Wegovy #Obésité

'As much as 40% of all weight lost on GLP-1s is lean muscle, says Mahmoud Salama Ahmed, a medical chemist at Texas Tech University. While muscle loss is standard with any diet or weight-loss regimen, loss of muscle on GLP-1s can be more dramatic, Ahmed says, causing what's been dubbed "Ozempic face," a bonier, looser-skinned look, where the muscle loss is particularly noticeable.'

https://www.npr.org/2026/04/15/nx-s1-5712532/glp-1-quit-begin-ozempic-wegovy-mounjaro-zepbound

#glp-1 #ozempic #wegovy

#FDA Approves #Foundayo: The New Once-Daily GLP-1 Pill vs. #Wegovy

As the second oral #GLP1 pill to hit the market—following the December 2025 approval of the Wegovy pill — Foundayo is being hailed as a “game-changer” for its unique dosing flexibility.

https://www.dietofcommonsense.com/fda-approved-foundayo-for-weight-loss/

#Foundayo vs. #Wegovy Pill: 2026 Comparison of #WeightLoss Pills, Cost, and Results

For millions of #Americans, the shift from weekly injections to a daily pill isn’t just about avoiding a poke—it’s about cost and lifestyle flexibility.

https://www.dietofcommonsense.com/foundayo-vs-wegovy-pill-weight-loss/

Noch rechtzeitig geschafft, dass mich Fahrdienst heim bringen konnte, sogar mit Labor.

Sie verschreibt mir Xigduo, auf Privatrezept. Das scheidet ca 1/3 der aufgenommenen Kalorien aus. Kostet ca 50 € im Monat 😲 aber IRGENDWAS muss passieren, habe wieder in 3 Monaten 4 kg zugenommen.

Und sie hat vorgeschlagen, dass ich vom #Trulicity auf eine andere Spritze (#Ozempic) wechsle, die besser fürs Gewicht abnehmen sein soll.
#Wegovy scheidet bei mir aus, weil das nicht bei #Diabetes einschlägt

Millions Of Americans Are Losing Weight With GLP-1s. Here’s How That’s Changing Retail.

https://vid.freedif.org/w/ui4XcrHHK8TuVH7VWj85Mn

Millions Of Americans Are Losing Weight With GLP-1s. Here’s How That’s Changing Retail.

PeerTube